This content is machine translated 1. Grant for Oncology Innovation Two Swiss winners During the ESMO Congress, the winners of Merck Serono’s inaugural Grant for Oncology Innovation (GOI) were announced and awarded. The award, which comes with grants totaling €1 million, is intended…
View Post 2 min This content is machine translated Cancer risk with contraception with IUD Neither baby nor cancer Recently, evidence has accumulated in the literature that intrauterine devices may reduce the risk of developing endometrial cancer. What is the current study situation on this? This question was explored…
View Post 6 min This content is machine translated Therapy for nail pathologies Splintering, discolored or deformed nails: what next? Nail diseases can be very disturbing for the patient cosmetically, but also functionally. Before deciding on therapy, it is important to determine whether the nail change is due to a…
View Post 4 min This content is machine translated Specific oncological and social problems Cancer in young adults: Experts call for treatment protocols Adolescents and young adults are a neglected age group in oncology. Younger cancer patients are also rarely included in studies – accordingly, their survival rate has hardly improved in recent…
View Post 4 min This content is machine translated Meningiomas Therapeutic options for recurrent or metastatic tumors A “Special Session” at the ESMO Congress focused on meningiomas. Although these brain tumors are primarily treated surgically, higher-grade meningiomas that can grow invasively may require radio or systems therapy.
View Post 4 min This content is machine translated Metastatic colorectal cancer Which first-line therapy for patients with wild-type RAS? At this year’s ESMO Congress in Madrid, treatment options for metastatic colorectal cancer were also discussed. Is there an optimal strategy for patients with a wild-type RAS mutation, and would…
View Post 2 min This content is machine translated RAINBOW Study New standard in the second line? Drugs that are well established in first-line advanced gastric cancer continue to achieve relatively poor survival prognoses in second-line settings. A new study (RAINBOW) now demonstrates the efficacy of ramucirumab…
View Post 2 min This content is machine translated Glioblastoma Moving forward with combined forces Considering that glioblastomas are among the most common and malignant brain tumors and have a very poor prognosis, optimizations of the current therapy are urgently needed. Two publications are attracting…
View Post 2 min This content is machine translated Lymphoma as a result of breast implants Beauty at what price? A potentially new subcategory of anaplastic large cell lymphoma shows an association with breast implants. Researchers have compiled evidence from the 71 cases published to date. The main characteristics of…
View Post 7 min This content is machine translated New therapies Progress in metastatic malignant melanoma New insights in tumor biology and immunology as well as in molecular pathology have rapidly driven the development of immunomodulatory antibodies and so-called “targeted” therapeutics [1]. This makes the therapy…
View Post 6 min This content is machine translated Actinic keratosis Early treatment is indicated Actinic or solar keratoses represent in situ squamous cell carcinomas of the skin and are one of the more common dermatoses in daily practice. On the one hand, it is…
